Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Feb 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1941661000001119 | Seffalair Spiromax (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1941671000001112 | Seffalair Spiromax | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Seffalair Spiromax | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Seffalair Spiromax 12.75micrograms/dose / 100micrograms/dose dry powder inhaler (Teva UK Ltd) | Is a | True | Seffalair Spiromax | Inferred relationship | Existential restriction modifier | |
| Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) | Is a | True | Seffalair Spiromax | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR